Grant: Discovery Grants Program - Individual
Brock University
$69,000.00
Monoterpenoid indole alkaloid biosynthesis
FY 2020-21
Summary
Plants
have remarkable attributes for being able to perform complex and biologically
innovative biochemistry that generates a diversity of colors, fragrances, aromas
and biologically active organic molecules. While the majority of the molecules produced are
not directly essential for survival, many may play key roles in plant
adaptation to the biotic and abiotic environment. The unique biological
activities of this chemical diversity have provided medicinal and disease
preventing molecules that have been used by humanity to prevent/cure many
devastating diseases. The monoterpenoid indole alkaloids (MIAs) make
up the largest and most diverse class of compounds that are characteristically
found within many members of the Apocynaceae (4700 species), the Loganiaceae
(600 species) and the Rubiaceae (> 10,000 species) plant families. The
complexity of MIA chemistry is matched by their remarkably diverse effects on
living organisms that has led to their use as drugs for preventing malaria
(quinine) and for treating neurological disorders (reserpine), cancer
(camptothecin, vinblastine and vincristine), as vasodilators (yohimbine), as
anti-inflammatories for gout treatments (colchicine) and as potential analgesics and novel pain
killers (conolidine) in human beings. Over the past >25 years my laboratory
has made many key discoveries about the biosynthesis of
anti-cancer MIAs of the Madagascar periwinkle (Catharanthus roseus) that have been used in chemotherapy treatments
over the past 45 years. The genetic resources and biochemical knowledge derived from these discoveries are
presently being exploited to enhance the production of valuable medicinal
compounds in C. roseus or through synthetic biology experiments in other organisms including yeast or in microbial
factories. The production of MIA pharmaceuticals in recombinant organisms
creates unique opportunities for less expensive manufacturing of existing MIA drugs
and for generating new and unique medicines not available from natural sources. The initial discoveries made in this model plant have also greatly improved the tools available for gene discovery of other MIA pathways found in Nature and for learning about the ecological roles that MIAs play in plant fitness and adaptations to their environment.
Program
Discovery Grants Program - Individual
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
RGPIN-2017-04145
Name nom
De Luca, Vincenzo
Department département
Biological sciences
Organization id
22
Institution établissement
Brock University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2020
Competition year année de concours
2017
Award amount
69000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1502
Committee name en
Biological Systems and Functions
Committee name fr
Systèmes et fonctions biologiques
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5408
Research subject group en
Biochemistry
Research subject group fr
Biochimie
Research subject en
Metabolism
Research subject fr
Métabolisme
Installment
inst:4-5
Partie
2
Nb partie
5
Application title
Monoterpenoid indole alkaloid biosynthesis
Keyword
NSERC
Application summary
Plants
have remarkable attributes for being able to perform complex and biologically
innovative biochemistry that generates a diversity of colors, fragrances, aromas
and biologically active organic molecules. While the majority of the molecules produced are
not directly essential for survival, many may play key roles in plant
adaptation to the biotic and abiotic environment. The unique biological
activities of this chemical diversity have provided medicinal and disease
preventing molecules that have been used by humanity to prevent/cure many
devastating diseases. The monoterpenoid indole alkaloids (MIAs) make
up the largest and most diverse class of compounds that are characteristically
found within many members of the Apocynaceae (4700 species), the Loganiaceae
(600 species) and the Rubiaceae (> 10,000 species) plant families. The
complexity of MIA chemistry is matched by their remarkably diverse effects on
living organisms that has led to their use as drugs for preventing malaria
(quinine) and for treating neurological disorders (reserpine), cancer
(camptothecin, vinblastine and vincristine), as vasodilators (yohimbine), as
anti-inflammatories for gout treatments (colchicine) and as potential analgesics and novel pain
killers (conolidine) in human beings. Over the past >25 years my laboratory
has made many key discoveries about the biosynthesis of
anti-cancer MIAs of the Madagascar periwinkle (Catharanthus roseus) that have been used in chemotherapy treatments
over the past 45 years. The genetic resources and biochemical knowledge derived from these discoveries are
presently being exploited to enhance the production of valuable medicinal
compounds in C. roseus or through synthetic biology experiments in other organisms including yeast or in microbial
factories. The production of MIA pharmaceuticals in recombinant organisms
creates unique opportunities for less expensive manufacturing of existing MIA drugs
and for generating new and unique medicines not available from natural sources. The initial discoveries made in this model plant have also greatly improved the tools available for gene discovery of other MIA pathways found in Nature and for learning about the ecological roles that MIAs play in plant fitness and adaptations to their environment.